Krsnaa Diagnostics
KRSNAA NSE
Krsnaa Diagnostics
Healthcare ServicesNSE: KRSNAA BSE: 543328 Healthcare Service Provider
Key Fundamentals
MicrocapHealthcare Service ProviderHealthcare ServicesMarket Cap
₹1,783 Cr
Volatility
Moderate
P/E Ratio
18.04
EBITDA
₹212 Cr
Return on Equity
8.79%
Debt to Equity
0.54
Book Value
₹302.23
EPS
₹18.62
52W High
₹894.4
52W Low
₹515
Tapetide Score
Data-driven rating, 0–100. How it works →
Key Insights
Weaknesses
5- The company has delivered a poor sales growth of 11.8% over past five years.
- Promoter holding is low: 27.1%
- Company has a low return on equity of 9.34% over last 3 years.
- Company has high debtors of 163 days.
- Working capital days have increased from 25.4 days to 65.9 days
Growth Rate
Revenue Growth
4.05% lower than
3Y
Net Income Growth
36.56% higher than
3Y
Cash Flow Change
259% higher than
3Y
ROE
25.21% higher than
3Y
ROCE
34.29% higher than
3Y
EBITDA Margin (Avg.)
-10.64% lower than
3Y
Quarterly Results
| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 132 | 147 | 152 | 159 | 163 | 179 | 165 | 175 | 176 | 183 | 159 | 173 | 211 |
| Expenses | 100 | 116 | 113 | 116 | 120 | 126 | 117 | 121 | 126 | 125 | 112 | 116 | 154 |
| Operating Profit | 32 | 31 | 38 | 43 | 43 | 52 | 48 | 53 | 50 | 58 | 48 | 57 | 57 |
| OPM % | 24% | 21% | 25% | 27% | 26% | 29% | 29% | 31% | 29% | 32% | 30% | 33% | 27% |
| Other Income | 4 | 4 | 4 | 4 | 7 | 5 | 9 | 4 | 4 | 4 | 4 | 31 | 7 |
| Interest | 2 | 3 | 4 | 7 | 5 | 6 | 6 | 7 | 6 | 8 | 8 | 12 | 15 |
| Depreciation | 16 | 18 | 21 | 18 | 21 | 22 | 23 | 22 | 22 | 23 | 23 | 22 | 28 |
| PBT | 19 | 14 | 17 | 22 | 24 | 28 | 28 | 29 | 26 | 31 | 21 | 54 | 22 |
| Tax % | 18% | 20% | 20% | 17% | 23% | 23% | 24% | 28% | 26% | 24% | 22% | 20% | 26% |
| Net Profit | 15 | 11 | 14 | 18 | 18 | 22 | 22 | 21 | 20 | 23 | 16 | 43 | 16 |
| EPS in Rs | 4.86 | 3.6 | 4.21 | 5.7 | 5.63 | 6.8 | 6.69 | 6.53 | 6.03 | 7.16 | 5.08 | 13.37 | 4.88 |
Profit & Loss
| Particulars | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 36 | 57 | 108 | 147 | 258 | 396 | 455 | 464 | 590 | 682 | 691 | 726 |
| Expenses | 35 | 42 | 169 | 87 | 373 | 302 | 320 | 340 | 444 | 485 | 478 | 507 |
| Operating Profit | 0 | 15 | -62 | 60 | -114 | 94 | 135 | 124 | 146 | 197 | 213 | 219 |
| OPM % | 0.6% | 26% | -57% | 41% | -44% | 24% | 30% | 27% | 25% | 29% | 31% | 30% |
| Other Income | 3 | 4 | 3 | 2 | 13 | 265 | 15 | 19 | 17 | 26 | 43 | 47 |
| Interest | 6 | 6 | 8 | 16 | 25 | 26 | 18 | 8 | 16 | 25 | 34 | 42 |
| Depreciation | 5 | 10 | 18 | 26 | 32 | 37 | 41 | 54 | 75 | 88 | 90 | 96 |
| PBT | -7 | 2 | -84 | 21 | -158 | 295 | 90 | 82 | 72 | 110 | 132 | 128 |
| Tax % | 6% | 8% | -29% | 40% | -29% | 37% | 21% | 23% | 19% | 24% | 22% | — |
| Net Profit | -8 | 2 | -60 | 12 | -112 | 185 | 71 | 64 | 59 | 83 | 103 | 99 |
| EPS in Rs | -15.05 | 4.01 | -117 | 24.15 | -217 | 285 | 22.52 | 20.23 | 18.14 | 25.65 | 31.65 | 30.49 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 11% | 14% | 14% | 11% | 6% | — |
Balance Sheet
| Particulars | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 5 | 5 | — | 5 | 5 | 6 | 16 | 16 | 16 | 16 | 16 |
| Reserves | 4 | 6 | — | 43 | -217 | -17 | 671 | 727 | 799 | 877 | 976 |
| Borrowings | 131 | 102 | — | 330 | 246 | 474 | 41 | 32 | 160 | 202 | 531 |
| Other Liabilities | 24 | 63 | — | 115 | 596 | 146 | 149 | 134 | 197 | 188 | 295 |
| Total Liabilities | 163 | 176 | — | 493 | 630 | 609 | 877 | 909 | 1,172 | 1,283 | 1,818 |
| Fixed Assets | 59 | 116 | — | 223 | 275 | 309 | 386 | 471 | 647 | 668 | 651 |
| CWIP | 20 | 6 | — | 42 | 9 | 4 | 28 | 25 | 10 | 3 | 208 |
| Investments | 0 | 0 | — | 0 | 0 | 0 | 0 | 0 | 0 | 32 | 58 |
| Other Assets | 85 | 53 | — | 228 | 345 | 297 | 463 | 413 | 514 | 581 | 902 |
| Total Assets | 163 | 176 | — | 493 | 630 | 609 | 877 | 909 | 1,172 | 1,283 | 1,818 |
Cash Flow
| Particulars | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | — | 59 | — | 61 | 38 | 119 | 129 | 75 | 24 | 89 | 134 |
| Investing | — | -53 | — | -201 | -77 | -67 | -241 | -109 | -129 | -102 | -391 |
| Financing | — | -37 | — | 145 | 6 | 20 | 176 | -33 | 84 | 14 | 278 |
| Net Cash Flow | — | -31 | — | 4 | -33 | 71 | 64 | -66 | -20 | 1 | 22 |
| Free Cash Flow | — | 6 | — | -42 | -39 | 50 | -2 | -59 | -169 | -21 | -80 |
| CFO/OP | — | 410 | — | 114 | -42 | 134 | 100 | 71 | 30 | 55 | 75 |
Ratios
| Particulars | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 87 | 91 | — | 140 | 87 | 69 | 48 | 59 | 110 | 152 | 163 |
| Inventory Days | 21 | 24 | — | 89 | — | — | — | — | — | — | 54 |
| Days Payable | 76 | 99 | — | 878 | — | — | — | — | — | — | 119 |
| Cash Conversion Cycle | 32 | 15 | — | -650 | 87 | 69 | 48 | 59 | 110 | 152 | 98 |
| Working Capital Days | -428 | -119 | — | -234 | -133 | -82 | -21 | 16 | -18 | 28 | 66 |
| ROCE % | — | 7% | — | — | -65% | 129% | 18% | 12% | 10% | 13% | 13% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Krsnaa Diagnostics insights
60 extracted metrics + investor summaries across FY16–FY26.
Documents
1
Intimation - Regulation 36(1)(B) Of The SEBI Listing Regulations
11 Sep - Krsnaa Diagnostics dispatched FY2025-26 annual report; 16th AGM scheduled for September 28, 2026. 11 Sep - Krsnaa Diagnostics dispatched FY2025-26 annual report; 16th AGM scheduled for September 28, 2026.
2
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
28 Apr - Krsnaa Diagnostics confirms it is not a Large Corporate under SEBI debt fundraising norms as of March 31, 2026. 28 Apr - Krsnaa Diagnostics confirms it is not a Large Corporate under SEBI debt fundraising norms as of March 31, 2026.
3
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
28 Apr - Krsnaa Diagnostics confirms it is not a Large Corporate under SEBI debt fundraising norms as of March 31, 2026. 28 Apr - Krsnaa Diagnostics confirms it is not a Large Corporate under SEBI debt fundraising norms as of March 31, 2026.
4
Board Meeting Held On April 17, 2026.
17 Apr - Board approved two independent directors, interim CFO appointment, three director cessations, and committee reconstitution effective April 25, 2026. 17 Apr - Board approved two independent directors, interim CFO appointment, three director cessations, and committee reconstitution effective April 25, 2026.
5
Announcement under Regulation 30 (LODR)-Change in Directorate
17 Apr - Board appointed two independent directors, an interim CFO, and approved director cessations effective April 2026. 17 Apr - Board appointed two independent directors, an interim CFO, and approved director cessations effective April 2026.
1
Announcement Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 9 Sept 2026
General_Announcements
Frequently Asked Questions about Krsnaa Diagnostics
What does Krsnaa Diagnostics Ltd do?
Krsnaa Diagnostics Ltd provides a range of technology-enabled diagnostic services such as imaging, clinical laboratory, and teleradiology services to hospitals, medical colleges, and community health centers across India with an extensive network across non-metro and lower-tier cities and towns.[1]
Where is Krsnaa Diagnostics Ltd (KRSNAA) listed?
Krsnaa Diagnostics Ltd trades as KRSNAA on the NSE and under code 543328 on the BSE.
Which sector does Krsnaa Diagnostics Ltd belong to?
Krsnaa Diagnostics Ltd is classified under the Healthcare Services sector, in the Healthcare Service Provider industry.
What is the market capitalisation of Krsnaa Diagnostics Ltd?
Krsnaa Diagnostics Ltd has a market capitalisation of ₹1,783 Cr, which places it in the Small Cap band.
What is the PE ratio of Krsnaa Diagnostics Ltd?
Krsnaa Diagnostics Ltd trades at a PE ratio of 18.04, on earnings per share of ₹18.62, against a book value of ₹302.23 per share.
What is the 52-week high and low of Krsnaa Diagnostics Ltd?
Over the last 52 weeks Krsnaa Diagnostics Ltd has traded between ₹515 and ₹894.4.
Does Krsnaa Diagnostics Ltd pay dividends?
Krsnaa Diagnostics Ltd has a dividend yield of 0.35%.
What is the Return on Equity (ROE) of Krsnaa Diagnostics Ltd?
Krsnaa Diagnostics Ltd reported a return on equity of 8.79%. Its debt-to-equity ratio is 0.54.
Company Information
Krsnaa Diagnostics Ltd provides a range of technology-enabled diagnostic services such as imaging, clinical laboratory, and teleradiology services to hospitals, medical colleges, and community health centers across India with an extensive network across non-metro and lower-tier cities and towns.[1]
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/KRSNAA.md for Krsnaa Diagnostics Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live,
structured queries instead of documents, use our MCP server.